5,8-difluoro-3-[1-(5-fluoro-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-amine
C19H14F3N5O — CID 146591927
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5,8-difluoro-3-[1-(5-fluoro-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-amine
5,8-difluoro-3-[1-(5-fluoro-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-amine (PubChem CID 146591927) has the molecular formula C19H14F3N5O and a molecular weight of 385.35 g/mol. Its IUPAC name is 5,8-difluoro-3-[1-(5-fluoro-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-amine.
Molecular Properties
| Compound Name | 5,8-difluoro-3-[1-(5-fluoro-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-amine |
|---|---|
| PubChem CID | 146591927 |
| Molecular Formula | C19H14F3N5O |
| Molecular Weight | 385.35 g/mol |
| Exact Mass | 385.12 |
| IUPAC Name | 5,8-difluoro-3-[1-(5-fluoro-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-amine |
| SMILES | CC(Oc1cc2c(F)ccc(F)c2nc1N)c1ncc(F)cc1-n1cccn1 |
| InChI | InChI=1S/C19H14F3N5O/c1-10(17-15(7-11(20)9-24-17)27-6-2-5-25-27)28-16-8-12-13(21)3-4-14(22)18(12)26-19(16)23/h2-10H,1H3,(H2,23,26) |
| InChIKey | CUJWQJCJYJBLOI-UHFFFAOYSA-N |
| XLogP | 3.95 |
| TPSA | 78.85 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 385.35 |
| LogP ≤ 5 | 3.95 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146591927 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.